The Venture Codex Logo

The Venture Codex

Ono Venture Investment

601 Gateway Blvd Suite 1010, South San Francisco, CA, 94080, USA

Overview

Corporate venture capital arm focused on pharmaceutical innovations.

Founded

2020

Deals · 12mo

1

Links

Website

Stage focus

Seed
Series A
Series B

Geographic focus

Japan
United Kingdom
United States

Sector focus

—

Investment portfolio

11rounds
NAMEDATESIZE
Violet Therapeutics
May 2026Participated
$5 MSeed
Alchemab Therapeutics
Sep 2025Participated
$32 MSeries A
AIRNA
Jul 2024Participated
$60 MSeries A
Mozart Therapeutics
Jun 2023Participated
$25 MSeries A
Violet Therapeutics
May 2023Participated
$11 MSeed
Curreio
Mar 2023Participated
$2 MSeries A
Mediar Therapeutics
Mar 2023Participated
$85 MSeries A
Switch Therapeutics
Mar 2023Participated
$52 MSeries A
Casma Therapeutics
Nov 2022Participated
$46 MSeries C
Arbor Biotechnologies
Nov 2021Participated
$215 MSeries B
Immunitas Therapeutics
Aug 2021Participated
$58 MSeries B
Violet Therapeutics
May 2026Participated
$5 MSeed
Alchemab Therapeutics
Sep 2025Participated
$32 MSeries A
AIRNA
Jul 2024Participated
$60 MSeries A
Mozart Therapeutics
Jun 2023Participated
$25 MSeries A
Violet Therapeutics
May 2023Participated
$11 MSeed
Curreio
Mar 2023Participated
$2 MSeries A
Mediar Therapeutics
Mar 2023Participated
$85 MSeries A
Switch Therapeutics
Mar 2023Participated
$52 MSeries A
Casma Therapeutics
Nov 2022Participated
$46 MSeries C
Arbor Biotechnologies
Nov 2021Participated
$215 MSeries B
Immunitas Therapeutics
Aug 2021Participated
$58 MSeries B
11
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Ono Venture Investment: 11 funding rounds are recorded in the selected participation categories.All available history.
Ono Venture Investment: 11 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Series A06
Series B02
Series C+01

Monthly Deal Activity

Ono Venture Investment: 11 deals are recorded across 63 months.All available history.
Ono Venture Investment: 11 deals are recorded across 63 months. All available history
MonthDeals
Aug '211
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '233
Apr '230
May '231
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Ono Venture Investment: Health & Life Sciences is the largest displayed sector by deal count (11 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Ono Venture Investment: Health & Life Sciences is the largest displayed sector by deal count (11 deals). All available history
SectorDeals
Health & Life Sciences11
Data, Analytics & IT1

Deal Size Distribution

Ono Venture Investment: 11 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Ono Venture Investment: 11 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M0
$10M-$25M1
$25M-$50M3
$50M-$100M4
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Ono Venture Investment: United States has the largest recorded deal count among the displayed regions (9 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Ono Venture Investment: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
RegionDeals
United States9
Japan1
Europe1
Ono Venture Investment: 20 co-investors are shown, with Eli Lilly and Company sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Ono Venture Investment: 20 co-investors are shown, with Eli Lilly and Company sharing 4 recorded deals. All available history
Co-investorShared deals
Eli Lilly and Company4
Alexandria Venture Investments3
ARCH Venture Partners3
Mass General Brigham Ventures3
Dementia Discovery Fund2
Leaps by Bayer2
Mirae Asset2
Novartis2
Pfizer Ventures2
Sofinnova Partners2
University of Tokyo Edge Capital2
120 Capital1
3S Capital1
AbbVie Ventures1
Agent Capital1
Ally Bridge Group1
Altitude Life Science Ventures1
Amgen Ventures1
ArrowMark Partners1
Asahi Kasei Pharma1

Investment Strategy

Ono Venture Investment: Led accounts for 0% and participating for 100% of round participation.All available history.
Ono Venture Investment: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating11100%
Ono Venture Investment: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Ono Venture Investment: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

HIROSHI YAMAMOTO

President & CEO

Shunichiro Matsumoto

CEO